Urine cell-free RNA for bladder cancer detection and treatment response prediction
Urine test may be able to detect and track bladder cancer
18 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 18 separate news trends connected to Diagnostics, spanning June 24, 2026 through October 3, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 166 article observations and 157 source signals, led by Health, Business, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
Urine test may be able to detect and track bladder cancer
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Startup raises $40M to accelerate women's health research with vaginal microbiome data
Rapid tests land in Congo as a leading doctor urges African nations to claim Ebola response ownership
A non-invasive urine test has been shown in trials to identify a vast majority of bladder cancer cases.
An AI that reads ECGs in under two seconds promises instant heart‑disease alerts, shifting diagnosis from weeks to moments.
A single blood sample is moving toward the ability to measure the biological age of individual organs, potentially predicting disease risk years in advance.
A single blood test could revolutionize cancer detection by identifying multiple cancers earlier.
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
Abbott Laboratories shares hit a three-month high and recorded their best day in 24 years following strong Q2 2026 results.
A new blood test may predict Alzheimer's risk up to a decade before symptoms appear.
Astronauts have successfully captured the first human X-rays in space, marking a significant milestone for extraterrestrial medical diagnostics.
New diagnostic tools, including blood and saliva tests, aim to reduce the years-long wait for endometriosis diagnosis.
9 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
New research and NICE guidance suggest non-invasive blood and saliva tests could soon be used to diagnose endometriosis via the NHS.
New diagnostic technologies recommended by NICE may significantly reduce the current nine-year wait for endometriosis diagnosis in the UK.
New blood tests using circular RNAs and protein markers are enabling the detection of Alzheimer's risk decades before symptoms appear.
A new multicomponent blood test is demonstrating higher detection rates for clinically significant prostate cancer compared to traditional PSA testing.